CDK3 and cancer: The mRNA expression of CDK3 in renal cancer tissues was much higher than in normal tissues, consistent with the survival analysis results, indicating that CDK3 was an unfavorable biomarkers for RCC and might participate in cancer progression (Fig. 5G).